Your browser doesn't support javascript.
loading
Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients.
Radaelli, M; Moiola, L; Sangalli, F; Esposito, F; Barcella, V; Ferrè, L; Rodegher, M; Colombo, B; Fazio, R; Martinelli, V; Comi, G.
Afiliação
  • Radaelli M; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy radaelli.marta@hsr.it.
  • Moiola L; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Sangalli F; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Esposito F; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Barcella V; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Ferrè L; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Rodegher M; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Colombo B; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Fazio R; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Martinelli V; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Comi G; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy.
Mult Scler ; 22(4): 511-9, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26199350
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / População Branca / Rituximab / Imunossupressores Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / População Branca / Rituximab / Imunossupressores Idioma: En Ano de publicação: 2016 Tipo de documento: Article